In obesity-prone mice, the inhibition of hypothalamic fractalkine reduces obesity-related inflammatory activity as demonstrated by the reduction of TNF-α and IL-1β levels and the decreased recruitment of bone marrow-derived cells to the hypothalamus. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.